Sickle Cell Research for Treatment and Cure

Sickle Cell Research for Treatment and Cure commemorates the 30th anniversary of the National Sickle Cell Anemia Control Act (P. L. 92-294). The law provided for establishment of voluntary sickle cell anemia screening and counseling programs; information and education programs for health professionals and the public; and research and research training in the diagnosis, treatment, and control of sickle cell anemia. Since then, the NHLBI has committed over $923 million for research programs to improve the lives of persons with sickle cell disease. The booklet describes a range of NHLBI activities, including the

• Penicillin Prophylaxis in Sickle Cell Disease Studies.
• Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
• Stroke Prevention Trials in Sickle Cell Anemia.

It also mentions examples of how basic science advances achieved prior to the 1970s enabled progress against sickle cell disease and describes ongoing studies to develop a cure.

Information about Document Format

This document is available for viewing, printing, and downloading (saving) in Adobe Acrobat's portable document format (PDF). You need the Acrobat Reader installed on your computer and configured to work in your browser to access the PDF version. When viewed or printed in the Acrobat Reader, the document appears as it does in the printed copy version.

If you do not have the Acrobat Reader, you may download a free copy from Adobe

Attention blind and visually impaired viewers:
Access.Adobe.Com is a tool that allows blind and visually impaired users to read any document in Adobe PDF. The tool converts PDF documents into simple HTML or ASCII text that can then be read by a number of common screen reading programs that synthesize the HTML as audible speech.

[PDF document, 432 K]